Bio ProtocolBIO#424C- rating
Financial layer for DeSci
$0.02302
↑ +$0.0004009 · +1.77% (24H)
Price chart
LiveNo data
Market data
Market cap$49.4M
Fully diluted valuation$76.46M
24H volume$9.96M
7D volume--
Circulating supply2,145,029,070.25
Max supply3.32B
Mined ratio64.61%
Next halving--
Market cap rank#424
Market share0.00%
All-time high$0.889
All-time low$0.0159
Price change (multiple periods)
1H+1.48%
24H+1.77%
7D-6.36%
14D-12.19%
30D-22.72%
90D-15.43%
YTD-43.50%
1Y-81.57%
04
Exchange distribution
1 | BIO/KRWBIO / KRW | $0.04709 | $6M | 29.06% | |
2 | BIO/USDTBIO / USDT | $0.02673 | $3.57M | 17.32% | |
3 | BIO/TRYBIO / TRY | $0.02537 | $1.79M | 8.66% | |
4 | BIO/USDTBIO / USDT | $0.02313 | $1.75M | 8.48% | |
5 | BIO/USDTBIO / USDT | $0.02276 | $975.54K | 4.73% | |
6 | BIO/USDTBIO / USDT | $0.04738 | $719.4K | 3.49% | |
7 | BIO/USDTBIO / USDT | $0.02258 | $574K | 2.78% | |
8 | BIO/USDTBIO / USDT | $0.0229 | $432.41K | 2.10% | |
9 | BIO/TRYBIO / TRY | $0.02278 | $393.31K | 1.91% | |
10 | BIO/USDTBIO / USDT | $0.02289 | $386.07K | 1.87% | |
11 | BIO/USDTBIO / USDT | $0.02567 | $322.77K | 1.56% | |
12 | BIO/USDTBIO / USDT | $0.02243 | $299.14K | 1.45% | |
13 | BIO/USDTBIO / USDT | $0.02608 | $262.06K | 1.27% | |
14 | BIO/USDTBIO / USDT | $0.02262 | $252.9K | 1.23% | |
15 | BIO/USDTBIO / USDT | $0.02291 | $225.59K | 1.09% | |
16 | BIO/USDTBIO / USDT | $0.02288 | $195.92K | 0.95% | |
17 | BIO/TRYBIO / TRY | $0.0227 | $170.93K | 0.83% | |
18 | BIO/WETHBIO / WETH | $0.02281 | $164.74K | 0.80% | |
19 | BIO/USDBIO / USD | $0.02594 | $133.65K | 0.65% | |
20 | BIO/USDTBIO / USDT | $0.0227 | $104.12K | 0.50% |
AI investment view
Based on historical content analysisWOOFUN Rating
C-
Overall score 41.8 / 100
Bio Protocol has an overall rating C-f C (total score 43.42), ranking high in market ecosystem, team governance, and economic model across six dimensions. The main point of deduction is safety compliance (0 points)—mainly affected by regulatory compliance (0 points), multiple-entry ratio (0 points), and other sub-items. Rating Team Conclusion: "Bio Protocol has relative advantages in market ecosystem, team governance, and economic model, but current shortcomings are focused on security and compliance." " It is recommended to observe small positions and wait for key sub-sectors to improve before increasing allocation weighting.
View Full Rating ReportRoadmap37.5 / 100F
Team74.6 / 100C
Market76.2 / 100C
Tokenomics44.5 / 100F
Security0 / 100F
Peer comparison
BINANCE-SMART-CHAIN peer assets| Metric | Bio ProtocolThis coin | BNBBNB | Gram (prev. Toncoin)GRAM | ChainlinkLINK |
|---|---|---|---|---|
| Current Price | $0.02302 | $587.07 | $1.43 | $8.4 |
| Market Cap | $49.4M | $78.18B | $3.9B | $6.29B |
| Market Cap Rank | #424 | #4 | #25 | #18 |
| 24H Change | +1.77% | +2.90% | +1.29% | +0.06% |
| 7D Change | -6.36% | +0.23% | -- | +1.00% |
| Consensus | -- | PoSA | PoS | -- |
| Max Supply | 3.32B | 200M | No cap | 1B |
| WOOFUN Rating | C- (41.77) | D (31.78) | D- (23.63) | D+ (37.55) |
| ETF Status | -- | -- | -- | -- |
News Updates
Live syncLoading...
Comments
No comments yet.